Jeffrey L. Wade
2020
Compensation breakdown
| Bonus | $184,967 |
|---|---|
| Option Awards | $671,790 |
| Salary | $456,372 |
| Stock Awards | $302,534 |
| Other | $13,839 |
| Total | $1,629,502 |
Wade received $671.8K in option awards, accounting for 41% of the total pay in 2020.
Wade also received $185K in bonus, $456.4K in salary, $302.5K in stock awards and $13.8K in other compensation.
Rankings
In 2020, Jeffrey L. Wade's compensation ranked 6,473rd out of 13,090 executives tracked by ExecPay. In other words, Wade earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,473 out of 13,090 | 51st |
Division Manufacturing | 2,665 out of 5,621 | 53rd |
Major group Chemicals And Allied Products | 1,075 out of 2,254 | 52nd |
Industry group Drugs | 929 out of 1,954 | 53rd |
Industry Pharmaceutical Preparations | 695 out of 1,459 | 52nd |
Pay ratio
| Jeffrey L. Wade's Pay | $1,629,502 |
|---|---|
| Median Employee's Pay | $185,844 |
| Pay Ratio | 9to 1 |
In 2020, the annual total compensation of Jeffrey L. Wade was $1,629,502.
The annual total compensation of the median employee at Lexicon Pharmaceuticals was $185,844.
The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 9 to one.
Wade's colleagues
We found six more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2020.
2020
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2020
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2020
Praveen Tyle
Lexicon Pharmaceuticals
Executive Vice President, Research and Development
2020
Alexander Santini
Lexicon Pharmaceuticals
Former Executive Vice President and Chief Commercial Officer
2020
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
2020
Brian Crum
Lexicon Pharmaceuticals
General Counsel
News
March 26, 2024
April 8, 2022
March 19, 2021
March 13, 2020
March 14, 2019